weight loss program semaglutide Clinic Portland | How Semaglutide Can Change Your Approach to Weight Loss | Semaglutide Weight Loss | Hormone Therapy | Low-T Semaglutide Weight Loss Program Flyer

At 5mg/ml : each unit contains 0.05mg (50mcg) of tirzepatide

A follow-up phase 2 study reported minimal adverse effects associated with this therapy (Stein et al., 2019), and there are several clinical trials further investigating this protein (NCT05234775, NCT04797247, NCT05004675, NCT03545438, NCT04034485, NCT04790513, NCT04806893, NCT04797104, NCT04798430, NCT03549260)

These peptides have their ends joined by chemical bridges , making them less flexible and harder for enzymes to break down

Mounjaro (Tirzepatide) Dual action: targets both GLP-1 and GIP receptors Strong appetite suppression & improved blood sugar control Clinical trials show average body weight loss up to 22.5% over 72 weeks Wegovy (Semaglutide) Targets GLP-1 receptors only Licensed in the UK for obesity and cardiovascular protection STEP trials show 1521% body weight loss A new 7.2mg dose is expected in late 2025, with results potentially matching Mounjaro Both treatments are once-weekly injections, prescribed alongside healthy diet and lifestyle changes